Recap: Augmedix Q4 Earnings
Portfolio Pulse from Benzinga Insights
Augmedix (NASDAQ:AUGX) reported Q4 earnings, beating estimated earnings by 10.0% with an EPS of $-0.09 versus an estimate of $-0.1. Revenue increased by $3.93 million from the same period last year. The company's past performance shows a consistent beat on EPS estimates, leading to a 13.0% share price increase the day after last quarter's earnings were announced.
March 18, 2024 | 8:10 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Augmedix reported a positive Q4 earnings surprise with an EPS of $-0.09, beating estimates by 10.0%, and a significant year-over-year revenue increase.
Augmedix's Q4 earnings beat and consistent history of surpassing EPS estimates, coupled with a significant revenue increase from the previous year, suggest a positive short-term impact on its stock price. The company's past performance, including a 13.0% share price increase following last quarter's earnings announcement, supports the expectation of a similar positive reaction.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100